Literature DB >> 33552020

An Optimized Bacteriophage Cocktail Can Effectively Control Salmonella in vitro and in Galleria mellonella.

Janet Y Nale1, Gurinder K Vinner1, Viviana C Lopez1, Anisha M Thanki1, Preeda Phothaworn2, Parameth Thiennimitr3, Angela Garcia4, Manal AbuOun4, Muna F Anjum4, Sunee Korbsrisate2, Edouard E Galyov1, Danish J Malik5, Martha R J Clokie1.   

Abstract

Salmonella spp. is a leading cause of gastrointestinal enteritis in humans where it is largely contracted via contaminated poultry and pork. Phages can be used to control Salmonella infection in the animals, which could break the cycle of infection before the products are accessible for consumption. Here, the potential of 21 myoviruses and a siphovirus to eliminate Salmonella in vitro and in vivo was examined with the aim of developing a biocontrol strategy to curtail the infection in poultry and swine. Together, the phages targeted the twenty-three poultry and ten swine prevalent Salmonella serotype isolates tested. Although individual phages significantly reduced bacterial growth of representative isolates within 6 h post-infection, bacterial regrowth occurred 1 h later, indicating proliferation of resistant strains. To curtail bacteriophage resistance, a novel three-phage cocktail was developed in vitro, and further investigated in an optimized Galleria mellonella larva Salmonella infection model colonized with representative swine, chicken and laboratory strains. For all the strains examined, G. mellonella larvae given phages 2 h prior to bacterial exposure (prophylactic regimen) survived and Salmonella was undetectable 24 h post-phage treatment and throughout the experimental time (72 h). Administering phages with bacteria (co-infection), or 2 h post-bacterial exposure (remedial regimen) also improved survival (73-100% and 15-88%, respectively), but was less effective than prophylaxis application. These pre-livestock data support the future application of this cocktail for further development to effectively treat Salmonella infection in poultry and pigs. Future work will focus on cocktail formulation to ensure stability and incorporation into feeds and used to treat the infection in target animals.
Copyright © 2021 Nale, Vinner, Lopez, Thanki, Phothaworn, Thiennimitr, Garcia, AbuOun, Anjum, Korbsrisate, Galyov, Malik and Clokie.

Entities:  

Keywords:  Galleria mellonella; Salmonella; bacteriophage; bacteriophage therapy; gastrointestinal enteritis

Year:  2021        PMID: 33552020      PMCID: PMC7858669          DOI: 10.3389/fmicb.2020.609955

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  64 in total

Review 1.  Questions associated with the development of novel drugs intended for the treatment of bacterial infections in veterinary species.

Authors:  Marilyn N Martinez; Jeffrey L Watts; Jeffrey M Gilbert
Journal:  Vet J       Date:  2019-04-20       Impact factor: 2.688

2.  Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.

Authors:  M L Beeton; D R Alves; M C Enright; A T A Jenkins
Journal:  Int J Antimicrob Agents       Date:  2015-05-27       Impact factor: 5.283

3.  The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016.

Authors: 
Journal:  EFSA J       Date:  2018-02-27

4.  Development of a broad-spectrum Salmonella phage cocktail containing Viunalike and Jerseylike viruses isolated from Thailand.

Authors:  Preeda Phothaworn; Rattaya Supokaivanich; Jiali Lim; Jochen Klumpp; Mohammed Imam; Elizabeth Kutter; Edouard E Galyov; Matthew Dunne; Sunee Korbsrisate
Journal:  Food Microbiol       Date:  2020-07-02       Impact factor: 5.516

5.  Isolation, Characterization, and Application of Bacteriophage LPSE1 Against Salmonella enterica in Ready to Eat (RTE) Foods.

Authors:  Chenxi Huang; Safiullah M Virk; Jianchun Shi; Yang Zhou; Stephan P Willias; Mohamed K Morsy; Hazem E Abdelnabby; Jie Liu; Xiaohong Wang; Jinquan Li
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

Review 6.  Bacteriophages as Alternatives to Antibiotics in Clinical Care.

Authors:  Danitza Romero-Calle; Raquel Guimarães Benevides; Aristóteles Góes-Neto; Craig Billington
Journal:  Antibiotics (Basel)       Date:  2019-09-04

Review 7.  The Use of Bacteriophages in the Poultry Industry.

Authors:  Katarzyna Żbikowska; Monika Michalczuk; Beata Dolka
Journal:  Animals (Basel)       Date:  2020-05-18       Impact factor: 2.752

8.  Non-typhoidal Salmonella serotypes, antimicrobial resistance and co-infection with parasites among patients with diarrhea and other gastrointestinal complaints in Addis Ababa, Ethiopia.

Authors:  Tadesse Eguale; Wondwossen A Gebreyes; Daniel Asrat; Haile Alemayehu; John S Gunn; Ephrem Engidawork
Journal:  BMC Infect Dis       Date:  2015-11-04       Impact factor: 3.090

Review 9.  Non-typhoidal Salmonella in the Pig Production Chain: A Comprehensive Analysis of Its Impact on Human Health.

Authors:  Joana Campos; Joana Mourão; Luísa Peixe; Patrícia Antunes
Journal:  Pathogens       Date:  2019-01-29

Review 10.  The global burden and epidemiology of invasive non-typhoidal Salmonella infections.

Authors:  Ruchita Balasubramanian; Justin Im; Jung-Seok Lee; Hyon Jin Jeon; Ondari D Mogeni; Jerome H Kim; Raphaël Rakotozandrindrainy; Stephen Baker; Florian Marks
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

View more
  8 in total

1.  Prophylactic Delivery of a Bacteriophage Cocktail in Feed Significantly Reduces Salmonella Colonization in Pigs.

Authors:  Anisha M Thanki; Guillaume Mignard; Robert J Atterbury; Paul Barrow; Andrew D Millard; Martha R J Clokie
Journal:  Microbiol Spectr       Date:  2022-05-17

Review 2.  Bacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics.

Authors:  Yrvin León; Christina S Faherty
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.968

3.  Impact of Phage CDHS-1 on the Transcription, Physiology and Pathogenicity of a Clostridioides difficile Ribotype 027 Strain, R20291.

Authors:  Janet Y Nale; Thekra Sideeq Al-Tayawi; Shaun Heaphy; Martha R J Clokie
Journal:  Viruses       Date:  2021-11-11       Impact factor: 5.048

Review 4.  Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia.

Authors:  Mark B Carascal; Donna May Dela Cruz-Papa; Roland Remenyi; Mely Cherrylynne B Cruz; Raul V Destura
Journal:  Front Microbiol       Date:  2022-01-27       Impact factor: 5.640

5.  Genetic Mining of Newly Isolated Salmophages for Phage Therapy.

Authors:  Julia Gendre; Mireille Ansaldi; David R Olivenza; Yann Denis; Josep Casadesús; Nicolas Ginet
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 6.  In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success.

Authors:  Tea Glonti; Jean-Paul Pirnay
Journal:  Viruses       Date:  2022-07-07       Impact factor: 5.818

7.  Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection.

Authors:  Mengting Guo; Ya Gao; Yibing Xue; Yuanping Liu; Xiaoyan Zeng; Yuqiang Cheng; Jingjiao Ma; Hengan Wang; Jianhe Sun; Zhaofei Wang; Yaxian Yan
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

8.  Development of a Phage Cocktail to Target Salmonella Strains Associated with Swine.

Authors:  Anisha M Thanki; Viviana Clavijo; Kit Healy; Rachael C Wilkinson; Thomas Sicheritz-Pontén; Andrew D Millard; Martha R J Clokie
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.